Exenatide, 98%

Name: Exenatide, 98% | 141758-74-9
Brand: J&K Chemical
SKU: JK425531_25_MG
Price: 104.48 USD
Availability: OutOfStock

Cat. No JK425531_25_MG

Vendor: J&K Chemical

Product Information

Product Name

Exenatide, 98%

Brand Name

J&K

Product Number

425531

CAS

141758-74-9

Molecular Formula

C184H282N50O60S

Molecular Weight

4186.57

Certificate of Analysis (COA)

COA not found

General Information

Synonyms

Exendin-4

PubChem CID

45588096

IUPAC Name

(4S)-5-2-(2S,3R)-1-(2S)-1-(2S,3R)-1-(2S)-1-(2S)-1-(2S)-1-(2S)-1-(2S)-6-amino-1-(2S)-5-amino-1-(2S)-1-(2S)-1-(2S)-1-(2S)-1-(2S)-1-(2S)-1-(2S)-1-(2S)-1-(2S)-1-(2S,3S)-1-(2S)-1-(2S)-1-(2S)-1-(2S)-6-amino-1-(2S)-4-amino-1-2-2-(2S)-2-(2S)-1-(2S)-1-2-(2S)-1-(2S)-2-(2S)-2-(2S)-2-(2S)-1-amino-3-hydroxy-1-oxopropan-2-ylcarbamoylpyrrolidine-1-carbonylpyrrolidine-1-carbonylpyrrolidin-1-yl-1-oxopropan-2-ylamino-2-oxoethylamino-3-hydroxy-1-oxopropan-2-ylamino-3-hydroxy-1-oxopropan-2-ylcarbamoylpyrrolidin-1-yl-2-oxoethylamino-2-oxoethylamino-1,4-dioxobutan-2-ylamino-1-oxohexan-2-ylamino-4-methyl-1-oxopentan-2-ylamino-3-(1H-indol-3-yl)-1-oxopropan-2-ylamino-4-carboxy-1-oxobutan-2-ylamino-3-methyl-1-oxopentan-2-ylamino-1-oxo-3-phenylpropan-2-ylamino-4-methyl-1-oxopentan-2-ylamino-5-carbamimidamido-1-oxopentan-2-ylamino-3-methyl-1-oxobutan-2-ylamino-1-oxopropan-2-ylamino-4-carboxy-1-oxobutan-2-ylamino-4-carboxy-1-oxobutan-2-ylamino-4-carboxy-1-oxobutan-2-ylamino-4-methylsulfanyl-1-oxobutan-2-ylamino-1,5-dioxopentan-2-ylamino-1-oxohexan-2-ylamino-3-hydroxy-1-oxopropan-2-ylamino-4-methyl-1-oxopentan-2-ylamino-3-carboxy-1-oxopropan-2-ylamino-3-hydroxy-1-oxopropan-2-ylamino-3-hydroxy-1-oxobutan-2-ylamino-1-oxo-3-phenylpropan-2-ylamino-3-hydroxy-1-oxobutan-2-ylamino-2-oxoethylamino-4-2-(2S)-2-amino-3-(1H-imidazol-4-yl)propanoylaminoacetylamino-5-oxopentanoic acid

InChI Key

HTQBXNHDCUEHJF-XWLPCZSASA-N

SMILES

CCC@H(C)C@@H(C(=O)NC@@H(CCC(=O)O)C(=O)NC@@H(CC1=CNC2=CC=CC=C21)C(=O)NC@@H(CC(C)C)C(=O)NC@@H(CCCCN)C(=O)NC@@H(CC(=O)N)C(=O)NCC(=O)NCC(=O)N3CCCC@H3C(=O)NC@@H(CO)C(=O)NC@@H(CO)C(=O)NCC(=O)NC@@H(C)C(=O)N4CCCC@H4C(=O)N5CCCC@H5C(=O)N6CCCC@H6C(=O)NC@@H(CO)C(=O)N)NC(=O)C@H(CC7=CC=CC=C7)NC(=O)C@H(CC(C)C)NC(=O)C@H(CCCNC(=N)N)NC(=O)C@H(C(C)C)NC(=O)C@H(C)NC(=O)C@H(CCC(=O)O)NC(=O)C@H(CCC(=O)O)NC(=O)C@H(CCC(=O)O)NC(=O)C@H(CCSC)NC(=O)C@H(CCC(=O)N)NC(=O)C@H(CCCCN)NC(=O)C@H(CO)NC(=O)C@H(CC(C)C)NC(=O)C@H(CC(=O)O)NC(=O)C@H(CO)NC(=O)C@H(C@@H(C)O)NC(=O)C@H(CC8=CC=CC=C8)NC(=O)C@H(C@@H(C)O)NC(=O)CNC(=O)C@H(CCC(=O)O)NC(=O)CNC(=O)C@H(CC9=CNC=N9)N

Safety Information

Storage Condition

Freezer -20℃

References Data Source From Pubchem

Discovery and identification of semaphorin 4D as a bioindicator of high fracture incidence in type 2 diabetic mice with glucose control

Publication Name: Journal of Advanced Research

Publication Date: 2026-01

DOI: 10.1016/j.jare.2025.03.014

Exploring the potential impact of GLP-1 receptor agonists in cancer therapy

Publication Name: Minerva Endocrinology

Publication Date: 2025-10

DOI: 10.23736/s2724-6507.23.04101-5

Therapeutic effects of finerenone and exenatide on diabetes-induced heart failure: A combined approach targeting inflammation and oxidative stress

Publication Name: European Journal of Pharmacology

Publication Date: 2025-09-05

DOI: 10.1016/j.ejphar.2025.177826

A systematic review on the role of glucagon-like peptide-1 receptor agonists on alcohol-related behaviors: potential therapeutic strategy for alcohol use disorder

Publication Name: Acta Neuropsychiatrica

Publication Date: 2025-09-03

DOI: 10.1017/neu.2025.10038|10.1017/neu.2025.4|10.1017/neu.2025.6

The role of vasopressin deficiency in the fluid intake suppression hyper-responsivity to central glucagon-like peptide-1 in the Brattleboro rat

Publication Name: Physiology & Behavior

Publication Date: 2025-09-01

DOI: 10.1016/j.physbeh.2025.114958